ARCHIVES

FDA Approves Arranon For Leukemia And Lymphoma

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | December 30, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

DCCP Payback System Saving $1 Million Year

December 3, 1982

Breast Cancer Progress Report Summaries

November 14, 1975

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994